Vireo Growth (VREOF) EBIT (2020 - 2026)
Vireo Growth (VREOF) reported EBIT of $9.0 million for Q1 2026, up 350.0% on a YoY basis from $2.0 million in Q1 2025, and up 596.02% sequentially from -$1.8 million in Q4 2025.
Vireo Growth (VREOF) EBIT (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of EBIT data on file, last reported at $9.0 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 350.0% year-over-year to $9.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (down 44.69% YoY), and the FY2025 full-year result was -$1.0 million, down 107.73% from the prior year.
- EBIT grew to $9.0 million in Q1 2026, from -$1.8 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $9.0 million in Q1 2026 to a low of -$7.8 million in Q1 2022.
- A 5-year average of $1.5 million and a median of $701765.0 in 2022 frame the typical range for EBIT.
- Peak annual rise in EBIT reached 3204.05% in 2023, while the deepest fall reached 438.12% in 2023.
- Tracing VREOF's EBIT over 5 years: stood at $701765.0 in 2022, then surged by 666.9% to $5.4 million in 2023, then tumbled by 115.64% to -$841550.0 in 2024, then sank by 115.61% to -$1.8 million in 2025, then soared by 596.02% to $9.0 million in 2026.
- Business Quant data shows VREOF's EBIT at $9.0 million in Q1 2026, -$1.8 million in Q4 2025, and $808956.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | -1.81 Mn |
| Sep 30, 2025 | 808,956.00 |
| Jun 30, 2025 | -2.02 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | -841,550.00 |
| Sep 30, 2024 | 3.85 Mn |
| Jun 30, 2024 | 5.79 Mn |
| Mar 31, 2024 | 4.76 Mn |
| Dec 31, 2023 | 5.38 Mn |
| Sep 30, 2023 | 5.87 Mn |
| Jun 30, 2023 | -1.04 Mn |
| Mar 31, 2023 | 368,506.00 |
| Dec 31, 2022 | 701,765.00 |
| Sep 30, 2022 | -189,156.00 |
| Jun 30, 2022 | 308,185.00 |
| Mar 31, 2022 | -7.76 Mn |
| Dec 31, 2021 | -8.26 Mn |
| Sep 30, 2021 | -4.13 Mn |
| Jun 30, 2021 | -3.25 Mn |